CI vs IRD
Cigna Corp (CI) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CI and IRD stock pages for the full models.
Not investment advice.